CTRI/2024/04/066083尚未招募2 期
A COMPARATIVE STUDY BETWEEN OUTCOME OF JAK INHIBITORS (TOFACITINIB) AND NSAIDS ON PATIENTS WITH AXIAL SPONDYLOARTHROPATHIES - NI
Dr Nilotpal Saikia0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Diagnosed Cases of Ankylosing Spondylitis, 2. Patients with no Medical Contraindication, 3. Skeletally Mature Patients.
排除标准
- •1. Age less than 18 years, 2. Patients with active infections (tb & other viral and bacterial infection), 3. Pregnant, Lactating women.
研究者
相似试验
尚未招募
Unknown
A comparative study between efficacy of topical JAK inhibitor alone versus JAK inhibitor with phototherapy in vitiligo patientsCTRI/2024/07/070001Dr Sneha Ulhaskumar Arakeri
进行中（未招募）
不适用
A Randomized Study of the JAK Inhibitor INCB018424 Tablets Compared to Best Available Therapy in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) - COMFORT IIMedDRA version: 12.0Level: LLTClassification code 10028537Term: MyelofibrosisMyelofibrosisEUCTR2009-009858-24-ITIncyte Corporation150
招募中
4 期
Investigating the role of JAK inhibition in achieving and maintaining disease remission in psoriatic arthritis (PsA).Psoriatic Arthritis2024-511401-40-00UZ Leuven20
进行中（未招募）
1 期
Investigating the role of JAK inhibition in achieving and maintaining disease remission in psoriatic arthritis (PsA).MedDRA version: 21.0Level: LLTClassification code: 10037160Term: Psoriatic arthritis Class: 10028395Psoriatic ArthritisCTIS2024-511401-40-00Z Leuven20
已完成
不适用
Effect of Jalaukavacharana and Triphala Guggulu with Moolakadi Avgaahan in Thrombosed HaemorrhoidsCTRI/2021/03/031801Principal cum Dean RGGPG Ayurvedic College and Hospital Paprola20